NCT04019405

Brief Summary

Participants aged 80 years or over, who attend Castle Hill Hospital with either stable angina or an acute coronary syndrome will be invited to participate in the study. After induction into the study, these participants will be assessed for frailty and quality of life (QoL) using predetermined assessment tools. Quality of life (QoL) will be assessed using the standardised SF-12 questionnaire proforma. Frailty assessment will be based on the use of the Fried Frailty Phenotype criteria and the Edmonton Frailty Scale. Patients will be reassessed at 3,9 and 24 months for their clinical outcomes, repeat frailty assessment and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 11, 2016

Completed
2.8 years until next milestone

First Posted

Study publicly available on registry

July 15, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

April 4, 2022

Status Verified

April 1, 2022

Enrollment Period

3.9 years

First QC Date

October 11, 2016

Last Update Submit

April 1, 2022

Conditions

Keywords

coronary artery diseaseelderlyrevascularisationfrailty

Outcome Measures

Primary Outcomes (1)

  • Change in Quality Of Life Questionnaire

    The primary out come will be quality of life assessed by SF-12 survey forms

    baseline and 3, 9 and 24 months

Secondary Outcomes (5)

  • Change in frailty Status - Fried frailty Criteria

    baseline and 3, 9 and 24 months

  • Change in frailty Status - Edmonton Frailty Score

    baseline and 3, 9 and 24 months

  • Major adverse clinical events during hospitalization

    baseline and 3, 9 and 24 months

  • Major Adverse Clinical Event

    24 months

  • Predictors of adverse outcome

    baseline and 3, 9 and 24 months

Study Arms (1)

Frailty status

Frailty status will be determined by prespecified assessment tools in the study protocol. These assessment tools will be Fried Frailty phenotype model and edmonton frailty Scale.

Eligibility Criteria

Age80 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients (male and female) aged 80 and over and who have a primary diagnosis of ischaemic heart disease will be eligible for participation in the study.

You may qualify if:

  • Aged 80 years and above and either
  • Have been seen in the cardiology out-patient department with a diagnosis of stable angina
  • Have been admitted to Castle Hill Hospital with non-ST elevation acute myocardial infarction (NSTEMI)
  • Have been admitted to Castle Hill Hospital with ST-elevation acute myocardial infarction (STEMI)
  • Have been referred to Castle Hill Hospital for coronary angioplasty
  • Have been referred to Castle Hill Hospital for coronary artery bypass graft surgery

You may not qualify if:

  • Patients will be excluded from the study in the event of any of the following:
  • Patients who are unable to provide informed consent including those with advanced dementia.
  • Patients, who are not able to speak good English sufficiently to be able to understand the study information, give consent and complete study measures.
  • Patients who have a primary diagnosis of significant valvular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Castle Hill Hospital

Cottingham, East Riding of Yorkshire NHS Trust, HU16 5JQ, United Kingdom

Location

MeSH Terms

Conditions

Coronary Artery DiseaseFrailty

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Angela Hoye, MB.ChB,PhD

    Hull and East Yorkshire NHS Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2016

First Posted

July 15, 2019

Study Start

July 1, 2016

Primary Completion

June 1, 2020

Study Completion

December 1, 2020

Last Updated

April 4, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

individual participant data will not be shared

Locations